Search for Clinical Trial Results

Sponsored By

Eosinophilic Granulomatosis With Polyangiitis - 2 Studies Found

Status Study
COMPLETED Study Name: Maintenance of Remission with Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis with Polyangiitis.
Condition: Eosinophilic Granulomatosis with Polyangiitis
Date: 2025-07-20
Interventions: pre-emptive 500-mg fixed-dose of IV rituximab every 6 months (total duration of 18 months = 4 infusions)
COMPLETED Study Name: FASENRA Regulatory Postmarketing Surveillance in Korea
Condition: Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)
Date: 2025-07-20